Neil Inhaber | Head, Rare Diseases, Global Medical Affairs
Takeda

Neil Inhaber, MD, FRCPC Head, Rare Diseases and Marketed Products Medical, Global Medical, Global Portfolio Division, Takeda Pharmaceuticals and Co-Chair, Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease Neil leads portfolio medical affairs strategy development with a focus on the support and planning of product and service launches in the US and internationally.  He brings 20+ years of academic and private practice experience as a critical care physician in the Unites States and Canada in addition to 15+ years of worldwide pharmaceutical, medical device, and biotechnology industry experience.  In previous roles, Neil headed teams in clinical development from early stage through commercialization and life cycle management and successfully engaged key stakeholders including the academic and scientific communities, payers, patient organizations, and key opinion leaders. Prior to joining Takeda, Neil served as Chief Medical Officer of Sequana Medical AG based in Zurich.  Earlier in his career, he held positions in medical affairs and clinical development at Jazz Pharmaceuticals, Novartis, Baxter, and Boston Scientific.  Neil received his BSc in Biomedical Engineering from Rensselaer Polytechnic Institute in Troy, NY, and an MD from McGill University in Montreal.